Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
25%
Ph not_applicable
1
25%
Ph phase_2
1
25%
Ph phase_1
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 21 (25.0%)
N/A1 (25.0%)

Trials by Status

completed250%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

NCT06801769
recruitingearly_phase_1

Effect of C-peptide on Hypoglycemic Counterregulation

NCT06470295
completedphase_1

Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers

NCT01665638
completedphase_2

Effect of C-Peptide on Diabetic Peripheral Neuropathy

NCT00278980

Clinical Trials (4)

Showing 4 of 4 trials
NCT06801769Not Applicable

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

Recruiting
NCT06470295Early Phase 1

Effect of C-peptide on Hypoglycemic Counterregulation

Recruiting
NCT01665638Phase 1

Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers

Completed
NCT00278980Phase 2

Effect of C-Peptide on Diabetic Peripheral Neuropathy

Completed

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4